Follow
Afsana Sheikh
Afsana Sheikh
Research Scholar, Jamia Hamdard
Verified email at jamiahamdard.ac.in - Homepage
Title
Cited by
Cited by
Year
3D printing in personalized drug delivery
V Jain, N Haider, K Jain
Current pharmaceutical design 24 (42), 5062-5071, 2018
1022018
RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy
A Sheikh, S Md, P Kesharwani
Journal of Controlled Release 340, 221-242, 2021
742021
CD44-targeted nanocarrier for cancer therapy
P Kesharwani, R Chadar, A Sheikh, WY Rizg, AY Safhi
Frontiers in pharmacology 12, 800481, 2022
672022
Gold nanoparticles and gold nanorods in the landscape of cancer therapy
P Kesharwani, R Ma, L Sang, M Fatima, A Sheikh, MAS Abourehab, ...
Molecular Cancer 22 (1), 98, 2023
612023
Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer
R Chadar, P Kesharwani
International Journal of Pharmaceutics 605, 120835, 2021
612021
An insight into aptamer engineered dendrimer for cancer therapy
A Sheikh, P Kesharwani
European Polymer Journal 159, 110746, 2021
562021
Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer
A Sheikh, S Md, P Kesharwani
Biomedicine & Pharmacotherapy 146, 112530, 2022
542022
Folic acid conjugated poly (amidoamine) dendrimer as a smart nanocarriers for tracing, imaging, and treating cancers over-expressing folate receptors
M Fatima, A Sheikh, N Hasan, A Sahebkar, Y Riadi, P Kesharwani
European Polymer Journal 170, 111156, 2022
522022
Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics
A Sheikh, S Md, NA Alhakamy, P Kesharwani
International Journal of Pharmaceutics 620, 121751, 2022
452022
Dostarlimab as a miracle drug: rising hope against cancer treatment
V Singh, A Sheikh, MAS Abourehab, P Kesharwani
Biosensors 12 (8), 617, 2022
432022
Recent progress of RGD modified liposomes as multistage rocket against cancer
A Sheikh, NA Alhakamy, S Md, P Kesharwani
Frontiers in Pharmacology 12, 803304, 2022
432022
Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer
U Rehman, N Parveen, A Sheikh, MAS Abourehab, A Sahebkar, ...
Colloids and Surfaces B: Biointerfaces 218, 112766, 2022
372022
A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy
P Kesharwani, A Sheikh, MAS Abourehab, R Salve, V Gajbhiye
Journal of Drug Delivery Science and Technology 80, 104164, 2023
352023
The clinical significance of 4D printing
A Sheikh, MAS Abourehab, P Kesharwani
Drug Discovery Today 28 (1), 103391, 2023
322023
Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer
Z Liu, N Parveen, U Rehman, A Aziz, A Sheikh, MAS Abourehab, W Guo, ...
Molecular Cancer 22 (1), 8, 2023
302023
Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer
N Hasan, M Imran, M Nadeem, D Jain, K Haider, MMA Rizvi, A Sheikh, ...
International Journal of Pharmaceutics 632, 122580, 2023
292023
Precision medicine: Ray of hope in overcoming cancer multidrug resistance
P Musyuni, J Bai, A Sheikh, KS Vasanthan, GK Jain, MAS Abourehab, ...
Drug Resistance Updates 65, 100889, 2022
282022
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
N Hasan, A Nadaf, M Imran, U Jiba, A Sheikh, WH Almalki, SS Almujri, ...
Molecular cancer 22 (1), 168, 2023
272023
Amelioration of full-thickness wound using hesperidin loaded dendrimer-based hydrogel bandages
P Gupta, A Sheikh, MAS Abourehab, P Kesharwani
Biosensors 12 (7), 462, 2022
272022
Itraconazole and difluorinated-curcumin containing chitosan nanoparticle loaded hydrogel for amelioration of onychomycosis
P Kesharwani, M Fatima, V Singh, A Sheikh, WH Almalki, V Gajbhiye, ...
Biomimetics 7 (4), 206, 2022
242022
The system can't perform the operation now. Try again later.
Articles 1–20